Search Results - "Wong, Grace L‐H"
-
1
Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection
Published in Annals of surgical oncology (01-12-2015)“…Background Approximately one-quarter of patients with Barcelona Clinic Liver Cancer (BCLC) stage 0/A hepatocellular carcinoma (HCC) suffer from tumor relapse…”
Get full text
Journal Article -
2
Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease
Published in Liver international (01-11-2020)“…Background & Aims Lifestyle modification is the cornerstone for the management of non‐alcoholic fatty liver disease (NAFLD). We aim to understand lifestyle…”
Get full text
Journal Article -
3
The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis
Published in Liver international (01-05-2023)“…Background Chronic hepatitis B (CHB) is endemic to Asia and is a leading cause of liver‐related morbidity. The prevalence of concomitant CHB and hepatic…”
Get full text
Journal Article -
4
Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors’ reply
Published in Alimentary pharmacology & therapeutics (01-01-2020)“…LINKED CONTENTThis article is linked to Brancaccio et al and Yuan et al papers. To view these articles, visit https://doi.org/10.1111/apt.15188 and…”
Get full text
Journal Article -
5
Development and validation of a model for hepatitis B e antigen seroconversion in entecavir‐treated patients with chronic hepatitis B
Published in Journal of medical virology (01-08-2020)“…Achieving hepatitis B e antigen (HBeAg) seroconversion is a satisfactory endpoint during antiviral treatment for chronic hepatitis B (CHB). This study aimed to…”
Get full text
Journal Article -
6
The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg‐negative chronic hepatitis B
Published in Liver international (01-03-2020)“…Background The rates of hepatitis B surface antigen (HBsAg) seroclearance after stopping nucleos(t)ide analogues (NA) in European (19% in 2 years) and Asian…”
Get full text
Journal Article -
7
Non-alcoholic fatty liver disease: Spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study
Published in Journal of hepatology (01-04-2014)“…Background & Aims Liver biopsy is the gold standard for diagnosing non-alcoholic fatty liver disease (NAFLD) but with practical constraints. Phosphorus…”
Get full text
Journal Article -
8
Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar
Published in PloS one (10-08-2017)“…In Myanmar, over five million people are infected with hepatitis B virus (HBV) and hepatitis C virus (HCV). Hepatitis has been a recent focus with the…”
Get full text
Journal Article -
9
Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply
Published in Alimentary pharmacology & therapeutics (01-06-2020)“…LINKED CONTENT This article is linked to Estes et al and Chuah and Chan papers. To view these articles, visit https://doi.org/10.1111/apt.15673 and…”
Get full text
Journal Article -
10
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Published in Proceedings of the National Academy of Sciences - PNAS (17-03-2015)“…Significance We used massively parallel sequencing to study the size profiles of plasma DNA samples at single-base resolution and in a genome-wide manner. We…”
Get full text
Journal Article -
11
International incidence and mortality trends of liver cancer: a global profile
Published in Scientific reports (31-03-2017)“…We examined the global incidence and mortality rates of liver cancer, and evaluated the association between incidence/mortality and socioeconomic development…”
Get full text
Journal Article -
12
Predictors of Treatment Response in Chronic Hepatitis B
Published in Drugs (New York, N.Y.) (12-11-2009)“…The ultimate goal of treatment for chronic hepatitis B is to reduce liver-related complications and mortality. Sustained hepatitis B e antigen (HBeAg)…”
Get full text
Journal Article -
13
Modelling NAFLD disease burden in four Asian regions—2019‐2030
Published in Alimentary pharmacology & therapeutics (01-04-2020)“…Summary Background Non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) account for an increasing proportion of liver disease in…”
Get full text
Journal Article -
14
Association of genetic variations with NAFLD in lean individuals
Published in Liver international (01-01-2022)“…Background & Aims How adiposity influences the effect of genetic variants on non‐alcoholic fatty liver disease (NAFLD) in the Asian population remains unclear…”
Get full text
Journal Article -
15
An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
Published in Nature communications (06-12-2018)“…Obesity increases the risk of hepatocellular carcinoma (HCC) especially in men, but the molecular mechanism remains obscure. Here, we show that an androgen…”
Get full text
Journal Article -
16
New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score
Published in Journal of gastroenterology and hepatology (01-09-2015)“…Background and Aim Serum albumin and bilirubin are the most significant independent prognostic factors to predict hepatic events in patients with primary…”
Get full text
Journal Article -
17
Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial
Published in The Lancet (British edition) (17-06-2017)“…Summary Background Present guidelines are conflicting for patients at high risk of both cardiovascular and gastrointestinal events who continue to require…”
Get full text
Journal Article -
18
Continuous Positive Airway Pressure Does Not Improve Nonalcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea. A Randomized Clinical Trial
Published in American journal of respiratory and critical care medicine (15-02-2021)“…Obstructive sleep apnea (OSA) is associated with development of nonalcoholic fatty liver disease (NAFLD). The effects of continuous positive airway pressure…”
Get full text
Journal Article -
19
Detecting Early‐Stage Liver Fibrosis Using Macromolecular Proton Fraction Mapping Based on Spin‐Lock MRI: Preliminary Observations
Published in Journal of magnetic resonance imaging (01-02-2023)“…Background Liver fibrosis is characterized by macromolecule depositions. Recently, a novel technology termed macromolecular proton fraction quantification…”
Get full text
Journal Article -
20
Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma
Published in Cancer research (Chicago, Ill.) (15-11-2015)“…The growing epidemic of obesity, which causes nonalcoholic fatty liver disease (NAFLD) and the more severe phenotype nonalcoholic steatohepatitis (NASH), has…”
Get full text
Journal Article